Camden Capital, LLC Amgen Inc Transaction History

Camden Capital, LLC

$896 Million
Q3 2024

A detailed history of Camden Capital, LLC transactions in Amgen Inc stock. As of the latest transaction made, Camden Capital, LLC holds 4,075 shares of AMGN stock, worth $1.07 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

4,075

Previous 2,249 81.19%

Holding current value

$1.07 Million

Previous $702,000 87.04%

% of portfolio

0.15%

Previous 0.06%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$309.38 - $337.38 $564,927 - $616,055	1,826 Added 81.19%	4,075 $1.31 Million
Q2 2024 Aug 06, 2024	BUY	$262.75 - $319.31 $248,824 - $302,386	947 Added 72.73%	2,249 $702,000
Q1 2024 May 15, 2024	SELL	$268.87 - $324.56 $287,690 - $347,279	-1,070 Reduced 45.11%	1,302 $370,000
Q4 2023 Feb 05, 2024	BUY	$255.7 - $288.46 $200,980 - $226,729	786 Added 49.56%	2,372 $683,000
Q3 2023 Nov 03, 2023	SELL	$218.65 - $271.46 $3,498 - $4,343	-16 Reduced 1.0%	1,586 $426,000
Q2 2023 Aug 09, 2023	BUY	$214.27 - $253.37 $32,569 - $38,512	152 Added 10.48%	1,602 $355,000
Q1 2023 May 11, 2023	BUY	$225.79 - $275.2 $28,901 - $35,225	128 Added 9.68%	1,450 $350,000
Q4 2022 Feb 13, 2023	SELL	$229.03 - $291.01 $63,441 - $80,609	-277 Reduced 17.32%	1,322 $347,000
Q3 2022 Nov 08, 2022	SELL	$224.46 - $253.15 $83,274 - $93,918	-371 Reduced 18.83%	1,599 $360,000
Q2 2022 Aug 03, 2022	BUY	$230.71 - $256.74 $20,533 - $22,849	89 Added 4.73%	1,970 $480,000
Q1 2022 May 06, 2022	BUY	$219.27 - $242.57 $30,039 - $33,232	137 Added 7.86%	1,881 $455,000
Q4 2021 Feb 28, 2022	SELL	$198.88 - $227.6 $212,801 - $243,532	-1,070 Reduced 38.02%	1,744 $392,000
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $5,966 - $6,828	-30 Reduced 1.05%	2,814 $633,000
Q3 2021 Nov 03, 2021	BUY	$212.27 - $248.7 $256,209 - $300,180	1,207 Added 73.73%	2,844 $605,000
Q2 2021 Aug 16, 2021	BUY	$233.58 - $259.14 $47,183 - $52,346	202 Added 14.08%	1,637 $399,000
Q1 2021 May 10, 2021	BUY	$221.91 - $258.6 $46,823 - $54,564	211 Added 17.24%	1,435 $357,000
Q4 2020 Feb 04, 2021	BUY	$216.38 - $257.67 $30,509 - $36,331	141 Added 13.02%	1,224 $281,000
Q3 2020 Oct 30, 2020	BUY	$234.65 - $260.95 $41,063 - $45,666	175 Added 19.27%	1,083 $275,000
Q2 2020 Aug 11, 2020	BUY	$197.81 - $242.74 $179,611 - $220,407	908 New	908 $214,000
Q1 2020 Apr 13, 2020	SELL	$182.24 - $241.7 $182,604 - $242,183	-1,002 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$189.21 - $243.2 $189,588 - $243,686	1,002 New	1,002 $242,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $140B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Camden Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Camden Capital, LLC with notifications on news.

Account

Camden Capital, LLC Amgen Inc Transaction History